Citigroup »

Apogee Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.2M 93k 66.45
2023-12-31 $105k 3.8k 27.94